US: AIHLF - Adcock Ingram Holdings Limited

Rentabilidade por seis meses: 0%

Cronograma de promoção Adcock Ingram Holdings Limited


Sobre a empresa

Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. It operates through four divisions: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services.

mais detalhes
The company is involved in the sale of various healthcare, personal care, and homecare products through FMCG retailers and corporate pharmacies; OTC medicinal products through corporate and independent pharmacies; branded and generic prescription products, and specialized instrumentation and surgical products; and hospital products and services. It offers its products for allergies, antiretroviral, baby care, cardiovascular, cannabidiol, central nervous system, colds and flu, cough, dermatology, digestive well-being, energy, feminine hygiene, food and nutrition supplements, gastroenterology, generics, ophthalmology, pain, personal care, respiratory, vitamins, minerals supplements, and women's health. The company also provides critical care products, including intravenous solutions, blood collection products, and renal dialysis systems. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.

EBITDA 17.94
EV/EBITDA 0.6991
Industry Pharmaceuticals
P/BV 0.161
P/E 1.08
P/S 0.0994
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 127.25
Див.доход ао 172.18
Дивиденд ао 1.59
Сайт https://www.adcock.co.za
Цена ао 2.45
Число акций ао 0.15463 млрд
Alteração de preço por dia: 0% (2.45)
Alteração de preço por semana: 0% (2.45)
Alteração de preço por mês: 0% (2.45)
Alteração de preço em 3 meses: 0% (2.45)
Mudança de preço em seis meses: 0% (2.45)
Mudança de preço por ano: 0% (2.45)
Mudança de preço em 3 anos: -21.97% (3.14)
Mudança de preço em 5 anos: -43.16% (4.31)
Mudança de preço em 10 anos: 0% (2.45)
Mudança de preço desde o início do ano: 0% (2.45)

Subestimação

Nome Significado Nota
P/S 0.7119 10
P/BV 0.0703 10
P/E 8.43 9
EV/EBITDA 7.25 9
Total: 8.63

Eficiência

Nome Significado Nota
ROA, % 1.02 1
ROE, % 1.58 1
Total: 1.67

Dividendos

Nome Significado Nota
Div yield, % 166.72 10
DSI 0.8571 8.57
Total: 8.51

Obrigação

Nome Significado Nota
Debt/EBITDA 3.55 3
Total: 5.8

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % -92.9 0
Rentabilidade Ebitda, % -92.56 0
Rentabilidade EPS, % 20.99 4
Total: 0.8

Supervisor Cargo Pagamento Ano de nascimento
Mr. Andrew Gideon Hall CA (SA), BPharm CEO & Executive Director 1962 (63 ano)
Ms. Dorette Neethling CFO & Executive Director 1974 (51 ano)
Ms. Basadifeela Letsoalo Executive Director of Transformation & Human Capital and Executive Director 1963 (62 ano)
R. Essa Corporate Finance Director
Mr. Mahlatse Phalafala Company Secretary & Head of Legal
Mr. Nkosinathi Mthethwa Public Affairs Executive
Mr. Ashley Pearce Dip. Pharm, BCom Managing Director of Prescription
Mr. Colin Sheen B.Tech., M.B.A., NDip Mktg, PDBA Managing Director of Hospital
Mr. Tobie Krige MBA Managing Director of Distribution
Mr. Azhar Kaka Head of Sales - Consumer Division

Endereço: South Africa, Midrand, 1 New Road - abrir no Google Maps, abrir mapas Yandex
Site: https://www.adcock.co.za